Skip to main content

Advertisement

SpringerLink
Log in

MTHFR 677TT genotype and toxicity of methotrexate: controversial results

  • Letter to the Editor
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. D’Angelo V, Ramaglia M, Ianotta A, Crisci S et al (2011) Methotrexate toxicity and efficacy during the consolidation phase in paediatric acute lymphoblastic leukaemia and MTHFR polymorphisms as pharmacogenetic determinants. Cancer Chemother Pharmacol. doi:10.1007/s00280-011-1665-1 (Published on line on 18 May 2011)

  2. Shimasaki N, Mori T, Samejima H, Sato R et al (2006) Effects of methylenetetrahydrofolate reductase and reduced folate carrier 1 polymorphisms on high-dose methotrexate-induced toxicities in children with acute lymphoblastic leukemia or lymphoma. J Pediatr Hematol Oncol 28(2):64–68

    Article  PubMed  CAS  Google Scholar 

  3. Horinouchi M, Yagi M, Imanishi H, Mori T et al (2010) Association of genetic polymorphisms with hepatotoxicity in patients with childhood acute lymphoblastic leukemia or lymphoma. Pediatr Hematol Oncol 27(5):344–354

    Article  PubMed  CAS  Google Scholar 

  4. Karathanasis NV, Stiakaki E, Goulielmos GN, Kalmanti M (2011) The role of the methylenetetrahydrofolate reductase 677 and 1298 polymorphisms in cretan children with acute lymphoblastic leukemia. Genet Test Mol Biomarkers 15(1–2):5–10

    Article  PubMed  CAS  Google Scholar 

  5. Chatzidakis K, Goulas A, Athanassiadou-Piperopoulou F, Fidani L et al (2006) Methylenetetrahydrofolate reductase C677T polymorphism: association with risk for childhood acute lymphoblastic leukemia and response during the initial phase of chemotherapy in greek patients. Pediatr Blood Cancer 47(2):147–151

    Article  PubMed  Google Scholar 

  6. Kishi S, Griener J, Cheng C, Das S et al (2003) Homocysteine, pharmacogenetics, and neurotoxicity in children with leukemia. J Clin Oncol 21(16):3084–3091

    Article  PubMed  CAS  Google Scholar 

  7. Pakakasama S, Kanchanakamhaeng K, Kajanachumpol S, Udomsubpayakul U et al (2007) Genetic polymorphisms of folate metabolic enzymes and toxicities of high dose methotrexate in children with acute lymphoblastic leukemia. Ann Hematol 86(8):609–611

    Article  PubMed  Google Scholar 

  8. Huang L, Tissing WJ, de Jonge R, van Zelst BD et al (2008) Polymorphisms in folate-related genes: association with side effects of high-dose methotrexate in childhood acute lymphoblastic leukemia. Leukemia 22(9):1798–1800

    Article  PubMed  CAS  Google Scholar 

  9. Lopez–Lopez E, Martin-Guerrero I, Ballesteros J, Piñan MA et al (2011) Polymorphisms of the SLCO1B1 gene predict methotrexate-related toxicity in childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. doi:10.1002/pbc.23074. (Published on line on 8 Mar 2011)

  10. Kishi S, Cheng C, French D, Pei D et al (2007) Ancestry and pharmacogenetics of antileukemic drug toxicity. Blood 109(10):4151–4157

    Article  PubMed  CAS  Google Scholar 

  11. Krajinovic M, Lemieux-Blanchard E, Chiasson S, Primeau M et al (2004) Role of polymorphisms in MTHFR and MTHFD1 genes in the outcome of childhood acute lymphoblastic leukemia. Pharmacogenomics J 4(1):66–72

    Article  PubMed  CAS  Google Scholar 

  12. Aplenc R, Thompson J, Han P, La M et al (2005) Methylenetetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemia. Cancer Res 65(6):2482–2487

    Article  PubMed  CAS  Google Scholar 

  13. Kantar M, Kosova B, Cetingul N, Gumus S et al (2009) Methylenetetrahydrofolate reductase C677T and A1298C gene polymorphisms and therapy-related toxicity in children treated for acute lymphoblastic leukemia and non-Hodgkin lymphoma. Leuk Lymphoma 50(6):912–917

    Article  PubMed  CAS  Google Scholar 

  14. van Kooten Niekerk PB, Schmiegelow K, Schroeder H (2008) Influence of methylene tetrahydrofolate reductase polymorphisms and coadministration of antimetabolites on toxicity after high dose methotrexate. Eur J Haematol 81(5):391–398

    PubMed  Google Scholar 

  15. Costea I, Moghrabi A, Laverdiere C, Graziani A et al (2006) Folate cycle gene variants and chemotherapy toxicity in pediatric patients with acute lymphoblastic leukemia. Haematologica 91(8):1113–1116

    PubMed  CAS  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Genetics, Physic Anthropology and Animal Physiology, Faculty of Medicine and Dentistry, University of the Basque Country, Barrio Sarriena s/n, 48940, Leioa, Spain

    Elixabet Lopez–Lopez & Africa Garcia-Orad

  2. Department of Neurosciences, University of the Basque Country, Leioa, Spain

    Javier Ballesteros

Authors
  1. Elixabet Lopez–Lopez
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Javier Ballesteros
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Africa Garcia-Orad
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Africa Garcia-Orad.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lopez–Lopez, E., Ballesteros, J. & Garcia-Orad, A. MTHFR 677TT genotype and toxicity of methotrexate: controversial results. Cancer Chemother Pharmacol 68, 1369–1370 (2011). https://doi.org/10.1007/s00280-011-1719-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00280-011-1719-4

Keywords

Search

Navigation